Shell or Merck: I Can Only Pick One Dividend Stock for the Next 10 Years. Here’s Mine

Roxanna Maglangit • 6 minute read
Reviewed by: Michael Douglass
Last updated Nov 16, 2026

@VanderWolf-Images from Getty Images via Canva, @Totojang from Getty Images Pro via Canva

Key Takeaways

  • Shell held its quarterly dividend at $0.3906 per ordinary share in October, up from $0.3580 a year earlier, while Merck beat on third-quarter earnings and raised its full-year guidance.
  • Shell paid out 27% of its free cash flow as dividends over its latest twelve months, against 66% at Merck.
  • Shell’s dividend is still below its fiscal 2015 level after a cut, while Merck’s grew 6% a year in the decade to fiscal 2025.
  • Merck’s Keytruda faces a patent cliff in 2028, and a Dutch court halted sales of its under-the-skin version in eight European countries in October.

Shell (SHEL) and Merck & Co. (MRK) both reported their third quarters on Oct. 29, and both kept the dividend checks coming. Shell declared $0.3906 per ordinary share for the quarter, up from $0.3580 a year earlier.

Merck beat on earnings and raised its full-year guidance, three weeks after a Dutch court halted sales of a new version of Keytruda, its best-selling drug, in eight European countries. On the call, CFO Caroline Litchfield said: “We remain committed to the dividend with the goal of increasing it over time.”

Shell pays the bigger yield, at 3.3% to Merck’s 2.3%. But 10 years is a long time to count on a check, so if I could only own one, which would it be?

MetricShell (SHEL)Merck & Co. (MRK)
Dividend yield3.3%2.3%
Dividend growth, fiscal 2020-202517.4% a year5.8% a year
Dividend growth, fiscal 2015-2025-2.6% a year6.2% a year
Cash dividend payout ratio (TTM)27% (to June 30, 2026)66% (to Sept. 30, 2026)
Net debt/EBITDA (TTM)0.5x1.5x
Interest coverage (TTM)7.8x5.2x
Forward P/E7.9x18x
Source: TIKR, at today’s prices

6 safe dividend stocks paying retirees 6%+ yields

There are over 100 stocks paying 6%+ annual dividends today.

But after an extensive investment review leveraging TIKR’s proprietary data, we now believe only six of them are truly safe for retirees.

They’re all yours as part of our new investment report. Learn more about how to get access right here.

Shell’s check has room to spare

Shell is leaning into gas. It took the final investment decision on the second phase of LNG Canada and closed its ARC Resources acquisition.

Shell’s dividend took a comfortable 27% of free cash flow over the twelve months to June 30, and no more than 35.4% in any of the last five fiscal years, even as free cash flow fell from $35.1 billion in fiscal 2024 to $23.9 billion in fiscal 2025:

Bar chart from TIKR of Shell's free cash flow vs. common dividends paid, $ billions, fiscal 2016–2025.
Shell (SHEL): free cash flow vs. common dividends paid, $ billions, fiscal 2016–2025 (TIKR)

Buybacks get most of what Shell hands back: $3.2 billion in the third quarter, against $2.2 billion of dividends. CFO Sinead Gorman called its aim of returning 40% to 50% of operating cash flow through the cycle “sacrosanct.” Shell sets the dividend in US dollars.

The risk is the one any oil company carries. Shell’s dividend fell from $1.88 a share in fiscal 2015 to $0.65 in fiscal 2020, and at $1.45 in fiscal 2025, it’s still below where it was a decade ago.

Merck’s record is steadier, but its cash is tighter

Where Shell’s dividend is still climbing back, Merck’s grew 6.2% a year from fiscal 2015 to fiscal 2025, from $1.80 to $3.28 a share. Third-quarter sales rose 5% to $18.1 billion, with Winrevair’s sales up 93% to $694 million, and Merck expects $66.8 billion to $67.3 billion of sales in 2026.

But the dividend takes a much bigger share of Merck’s cash: a heavy 66% of free cash flow over the twelve months to Sept. 30. Free cash flow fell from $18.1 billion in fiscal 2024 to $12.4 billion in fiscal 2025, so the ratio jumped from 43.3% to 66.1%, after hitting 81.4% in fiscal 2023:

Bar chart from TIKR of Merck's free cash flow vs. common dividends paid, $ billions, fiscal 2016–2025.
Merck (MRK): free cash flow vs. common dividends paid, $ billions, fiscal 2016–2025 (TIKR)

Keytruda is the risk. It faces its patent cliff in 2028, and on Oct. 7, a Dutch court ruled that Keytruda Qlex, the under-the-skin version meant to extend the franchise, infringes another company’s patent, halting its sales in eight European countries. Merck is appealing, and Litchfield calls the patent loss “really more of a hill on the overall revenues of our company.”

So which dividend wins?

If I can only pick one dividend stock for the next 10 years, it’s Shell.

Shell’s 17.4% five-year growth rate starts from its fiscal 2020 low, so I’d go by how each dividend is growing now: Shell’s rose 4.3% in fiscal 2025, and Merck’s 5.1%. At those paces, $10,000 in Shell pays about $4,021 over 10 years, against about $2,910 from Merck, and Merck’s check wouldn’t catch up for more than 30 years.

And I don’t have to pay up for it. Shell trades at 7.9x forward earnings, just under its five-year average of 8.1x and well below the 13.7x it reached in March:

Line chart from TIKR of Shell's forward (NTM) P/E, last 5 years.
Shell (SHEL): forward (NTM) P/E, last 5 years (TIKR)

This isn’t to say Merck’s dividend is in trouble. Its record is the steadier one, and management says it’s committed to raising the dividend. It’s just that over 10 years, I’d rather collect the bigger check with more cash behind it, even from a company that cut once.

Of course, oil prices could slide, and Shell’s Capital Markets update on Feb. 4 will show how it plans to split its cash from here.

Forget Shell: 6 safe 6%+ dividend yields you can buy right now

Dividends can hold the key to enormous wealth. But only if you buy the right ones.

Picking the right high-yield dividend stock can be the difference between a dream retirement…and scraping by every month, waiting for the next Social Security check to clear.

We’ve identified six stocks yielding 6%+ that we believe every retiree should know about right now. (And Shell isn’t one of them.)

Learn more here.

Disclaimer:

Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any of the stocks mentioned. Thank you for reading, and happy investing!

Join thousands of investors worldwide who use TIKR to supercharge their investment analysis.

Sign Up for FREENo credit card required